O'Brien Wealth Partners’s AbbVie ABBV Stock Holding History

O'Brien Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$627K	Hold	2,745	–	–	0.08%	45
2025 Q3	$636K	Buy	2,745 +2,003	+270%	+$408K	0.09%	43
2025 Q2	$138K	Sell	742 -13	-2%	-$2.42K	0.02%	56
2025 Q1	$158K	Buy	755 +21	+3%	+$4.08K	0.03%	50
2024 Q4	$130K	Hold	734	–	–	0.02%	51
2024 Q3	$145K	Sell	734 -14	-2%	-$2.61K	0.03%	49
2024 Q2	$128K	Hold	748	–	–	0.03%	47
2024 Q1	$136K	Sell	748 -900	-55%	-$155K	0.03%	49
2023 Q4	$255K	Hold	1,648	–	–	0.07%	38
2023 Q3	$246K	Hold	1,648	–	–	0.07%	35
2023 Q2	$222K	Hold	1,648	–	–	0.07%	40
2023 Q1	$263K	Sell	1,648 -80	-5%	-$12.2K	0.08%	35
2022 Q4	$279K	Buy	+1,728	New	+$265K	0.11%	33
2018 Q4	–	Sell	-734	Closed	-$69K	–	44
2018 Q3	$69K	Buy	+734	New	+$69.6K	0.04%	66
2018 Q2	–	Sell	-734	Closed	-$69K	–	92
2018 Q1	$69K	Buy	+734	New	+$80.6K	0.05%	53

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

O'Brien Wealth Partners's ABBV Position: Q4 2025 in Review

O'Brien Wealth Partners held its AbbVie (ABBV) position steady in Q4 2025 at 2,745 shares worth $627K. The position accounts for 0.08% of the portfolio, ranked #45.

O'Brien Wealth Partners first reported a position in ABBV in Q1 2018 and has held it in 15 quarters since. The position peaked at $636K in Q3 2025. 4,158 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

O'Brien Wealth Partners held 2,745 shares of AbbVie worth $627K as of Q4 2025.
O'Brien Wealth Partners left its AbbVie share count unchanged in Q4 2025.
AbbVie made up 0.08% of O'Brien Wealth Partners's portfolio in Q4 2025, its #45 holding.
O'Brien Wealth Partners first reported a position in AbbVie in Q1 2018 and has held it in 15 quarters since.
O'Brien Wealth Partners's AbbVie position peaked at $636K in Q3 2025.
4,158 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on O'Brien Wealth Partners's 13F filing for Q4 2025, filed 22 Jan 2026.